Rifat Atun

Author PubWeight™ 162.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011 11.89
2 An assessment of interactions between global health initiatives and country health systems. Lancet 2009 10.53
3 Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010 6.84
4 UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis 2012 5.42
5 Technologies for global health. Lancet 2012 5.05
6 Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 2011 5.00
7 Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments. Lancet 2010 3.73
8 Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev 2012 3.70
9 Universal access to malaria medicines: innovation in financing and delivery. Lancet 2010 3.31
10 Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev 2012 2.87
11 Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis 2012 2.62
12 Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 2005 2.44
13 Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev 2013 2.42
14 Mobile phone messaging for preventive health care. Cochrane Database Syst Rev 2012 2.15
15 Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One 2011 1.98
16 Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis 2012 1.89
17 Funding for malaria control 2006-2010: a comprehensive global assessment. Malar J 2012 1.87
18 Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development. PLoS Med 2012 1.81
19 Social, economic, human rights and political challenges to global mental health. Ment Health Fam Med 2011 1.72
20 Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis 2012 1.72
21 Market failure and the poverty of new drugs in maternal health. PLoS Med 2008 1.70
22 Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010 1.69
23 Guidance for evidence-informed policies about health systems: linking guidance development to policy development. PLoS Med 2012 1.68
24 Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health 2012 1.66
25 Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ 2011 1.64
26 Global health initiative investments and health systems strengthening: a content analysis of global fund investments. Global Health 2013 1.60
27 International and national policy challenges in mental health. Ment Health Fam Med 2011 1.58
28 An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries. Health Policy Plan 2012 1.58
29 Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D. Trop Med Int Health 2011 1.57
30 Health systems strengthening: a common classification and framework for investment analysis. Health Policy Plan 2010 1.56
31 Health system challenges and solutions to improving mental health outcomes. Ment Health Fam Med 2011 1.53
32 Beyond borders: public-health surveillance. Lancet 2006 1.49
33 Public-private partnerships for hospitals. Bull World Health Organ 2006 1.46
34 Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries. Cochrane Database Syst Rev 2011 1.41
35 Health systems, systems thinking and innovation. Health Policy Plan 2012 1.41
36 Integrating prevention of mother-to-child HIV transmission programs to improve uptake: a systematic review. PLoS One 2012 1.40
37 Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. Tuberculosis (Edinb) 2011 1.40
38 Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health Policy Plan 2012 1.34
39 Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother 2013 1.34
40 Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. PLoS One 2011 1.32
41 Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes. Health Policy 2007 1.31
42 Health systems, communicable diseases and integration. Health Policy Plan 2010 1.29
43 Mental health and the global agenda: core conceptual issues. Ment Health Fam Med 2011 1.28
44 Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia. Health Policy Plan 2010 1.23
45 Mobile phone messaging for communicating results of medical investigations. Cochrane Database Syst Rev 2012 1.23
46 Scaling up research and learning for health systems: time to act. Lancet 2008 1.22
47 Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi. J Int AIDS Soc 2011 1.22
48 Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance? J Antimicrob Chemother 2004 1.19
49 Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010. BMJ Open 2013 1.17
50 Long-term costs and health impact of continued global fund support for antiretroviral therapy. PLoS One 2011 1.16
51 The uptake of integrated perinatal prevention of mother-to-child HIV transmission programs in low- and middle-income countries: a systematic review. PLoS One 2013 1.14
52 Global Fund financing of public-private mix approaches for delivery of tuberculosis care. Trop Med Int Health 2011 1.11
53 Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010. J R Soc Med 2013 1.10
54 Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery. Bull World Health Organ 2007 1.08
55 Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding. BMJ Open 2014 1.05
56 Long-term care of AIDS and non-communicable diseases. Lancet 2011 1.04
57 Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Trop Med Int Health 2011 1.03
58 Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study. PLoS One 2012 1.01
59 Scaling up towards international targets for AIDS, tuberculosis, and malaria: contribution of global fund-supported programs in 2011-2015. PLoS One 2011 1.01
60 Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs. J Infect Dis 2012 0.99
61 Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. J Infect Dis 2012 0.99
62 Infectious disease research investments follow colonial ties: questionable ethics. Int Health 2014 0.97
63 HIV epidemics and prevention responses in Asia and Eastern Europe: lessons to be learned? AIDS 2010 0.96
64 Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review. PLoS Med 2012 0.95
65 Interactions between critical health system functions and HIV/AIDS, tuberculosis and malaria programmes. Health Policy Plan 2010 0.95
66 Adoption of rapid diagnostic tests for the diagnosis of malaria, a preliminary analysis of the Global Fund program data, 2005 to 2010. PLoS One 2012 0.94
67 Global health priorities and research funding--authors' reply. Lancet Infect Dis 2013 0.93
68 A conceptual and analytical approach to comparative analysis of country case studies: HIV and TB control programmes and health systems integration. Health Policy Plan 2010 0.93
69 Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009. J Infect Dis 2012 0.90
70 The Global Fund's resource allocation decisions for HIV programmes: addressing those in need. J Int AIDS Soc 2011 0.90
71 Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness. AIDS 2016 0.90
72 Should development agencies care about mental health? Ment Health Fam Med 2011 0.88
73 Public-private partnership in cord blood banking. BMJ 2008 0.88
74 Innovating for impact: the Affordable Medicines Facility-malaria (AMFm). Nat Med 2009 0.87
75 Indicators measuring the performance of malaria programs supported by the global fund in Asia, progress and the way forward. PLoS One 2011 0.87
76 Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective. J Acquir Immune Defic Syndr 2011 0.87
77 Negative health system effects of Global Fund's investments in AIDS, tuberculosis and malaria from 2002 to 2009: systematic review. JRSM Short Rep 2012 0.87
78 Know your epidemic, know your response: targeting HIV in Asia. AIDS 2010 0.87
79 Sexual and reproductive health activities in HIV programmes: can we monitor progress? J Epidemiol Community Health 2010 0.86
80 Unemployment, government healthcare spending, and cerebrovascular mortality, worldwide 1981-2009: an ecological study. Int J Stroke 2015 0.86
81 Emergence of multilateral proto-institutions in global health and new approaches to governance: analysis using path dependency and institutional theory. Global Health 2013 0.86
82 Venice Statement on global health initiatives and health systems. Lancet 2009 0.85
83 SMS text message healthcare appointment reminders in England. J Ambul Care Manage 2008 0.85
84 Sex, drugs and economic behaviour in Russia: a study of socio-economic characteristics of high risk populations. Int J Drug Policy 2010 0.84
85 HPTN 052 and the future of HIV treatment and prevention. Lancet 2011 0.83
86 Global Fund investments in harm reduction from 2002 to 2009. Int J Drug Policy 2012 0.83
87 Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010. BMJ Open 2014 0.83
88 How can mental health be integrated into health system strengthening? Ment Health Fam Med 2011 0.81
89 The effects of Global Fund financing on health governance in Brazil. Global Health 2012 0.81
90 Scaling up mental health services: where would the money come from? Ment Health Fam Med 2011 0.80
91 Mental health care reforms in Europe: Rehabilitation and social inclusion of people with mental illness in Russia. Psychiatr Serv 2010 0.80
92 Global fund financing of tuberculosis services delivery in prisons. J Infect Dis 2012 0.80
93 What action can national and international agencies take? Ment Health Fam Med 2011 0.79
94 Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK. Vaccine 2013 0.78
95 Seizing the opportunity to close the cancer divide. Lancet 2013 0.78
96 HIV in Asia: universal access in sight. AIDS 2010 0.77
97 Bridging the divide. J Acquir Immune Defic Syndr 2011 0.77
98 Maternal mortality for 181 countries, 1980-2008. Lancet 2010 0.77
99 Telephone consultation for improving health of people living with or at risk of HIV: a systematic review. PLoS One 2012 0.75
100 Public-private partnerships in health: time for evidence-based policies. Heart 2008 0.75
101 Beyond the bench and the bedside: economic and health systems dimensions of global childhood cancer outcomes. Pediatr Blood Cancer 2013 0.75
102 How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia. Int J Drug Policy 2010 0.75
103 Asia can afford universal access for AIDS prevention and treatment. AIDS 2010 0.75